Application of bioequivalence tests for combination products tops 87 items

Published: 2010-11-01 06:59:00

Updated: 2010-11-01 06:59:00

The Korea Food and Drug administration says that the number of bioequivalence tests for combination drugs is 87, which accounts for about 29 percent of total 296 drugs, applied for January and September 2010.

Of the 87 items, the combination drugs of olmesartan medoxomil and hydrochlorothiazid...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK